Efficacy and Predictors of Response to Biologic Therapy and Endoscopic Sinus Surgery in Patients With Nasal Polyps: A Systematic Review.

Xolair (omalizumab) - Roche, Novartis

Tezspire (tezepelumab-ekko) - AstraZeneca, Amgen

Nucala (mepolizumab) - GSK

Exdensur (depemokimab-ulaa) - GSK

Fasenra (benralizumab) - AstraZeneca

Dupixent (dupilumab) - Sanofi, Regeneron

http://www.ncbi.nlm.nih.gov/pubmed/42716513

Arun Chakravorty; Daniel M Beswick; Jeffrey Suh; Jess C Mace; Jivianne Lee; Justin Turner; Marilene Wang; Matthew E Lin; Myung Sim; Naweed Chowdhury; Rory Lubner; Sarah Wise; Timothy L Smith; Zachary M Soler

Sep 10, 2026